Noncoding RNA as Diagnostic and Prognostic Biomarkers in Cerebrovascular Disease

19Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Noncoding RNAs (ncRNAs), such as microRNAs, long noncoding RNAs, and circular RNAs, play an important role in the pathophysiology of cerebrovascular diseases (CVDs). They are effectively detectable in body fluids, potentially suggesting new biomarkers for the early detection and prognosis of CVDs. In this review, the physiological functions of circulating ncRNAs and their potential role as diagnostic and prognostic markers in patients with cerebrovascular diseases are discussed, especially in acute ischemic stroke, subarachnoid hemorrhage, and moyamoya disease.

Cite

CITATION STYLE

APA

Weng, R., Jiang, Z., & Gu, Y. (2022). Noncoding RNA as Diagnostic and Prognostic Biomarkers in Cerebrovascular Disease. Oxidative Medicine and Cellular Longevity. Hindawi Limited. https://doi.org/10.1155/2022/8149701

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free